akirin1 Antibody

What is Akirin1 and why is it important in research?

Akirin1 is a small nuclear protein (approximately 21.9 kDa) that belongs to the Akirin family, which includes Akirin1 and Akirin2 in vertebrates . It contains a highly conserved N-terminal nuclear localization signal (NLS) (Pro-Val-Lys-Arg-Arg) that directs it to the nucleus . Despite lacking obvious DNA- or RNA-binding motifs, Akirin1 plays crucial roles in transcriptional regulation .

Akirin1 is important in research due to its involvement in:

• Immune response regulation through NF-κB-dependent gene transcription

• Skeletal muscle development and myogenesis

• Ferroptosis regulation in kidney injury models

• Potential as a reference gene in NK cells and granulocytes in inflammatory conditions

What applications are Akirin1 antibodies suitable for?

Based on validated research applications, Akirin1 antibodies are primarily used in:

While some antibodies may be advertised for additional applications, researchers should validate antibodies for their specific experimental conditions .

What are the key considerations when selecting an Akirin1 antibody?

When selecting an Akirin1 antibody for research:

• Epitope location: Antibodies targeting different regions of Akirin1 may yield different results. Some target the N-terminal region , while others target the C-terminal region .

• Species reactivity: Most commercial Akirin1 antibodies react with human, mouse, and rat Akirin1 . Cross-reactivity should be verified when working with less common model organisms.

• Clonality: Most available Akirin1 antibodies are polyclonal, raised in rabbits . This offers high sensitivity but potential batch-to-batch variation.

• Validated applications: Ensure the antibody has been validated for your specific application through proper documentation and published literature .

How can I validate the specificity of an Akirin1 antibody?

Validation of Akirin1 antibodies should include:

• Positive controls: A549 cell lysate is commonly used as a positive control for Akirin1 antibody validation .

• Band size verification: The predicted molecular weight of Akirin1 is approximately 22 kDa, but observed band sizes may vary:

  • 22 kDa: Theoretical molecular weight

  • 27 kDa: Observed in some Western blots

  • 68 kDa: Observed in some cell lines, possibly due to post-translational modifications

• Blocking peptides: Some manufacturers offer peptide competitors (e.g., PEP-0726 for PA5-20606) that can be used to confirm specificity.

• Knockout/knockdown controls: Comparing antibody reactivity in wild-type versus Akirin1-knockout or Akirin1-knockdown samples provides the strongest validation .

What experimental conditions optimize Akirin1 antibody performance?

For optimal performance in Western blotting:

• Sample preparation: Nuclear extraction procedures are recommended as Akirin1 is primarily nuclear . Common lysis buffers containing detergents like NP-40 or RIPA are suitable.

• Blocking conditions: Most protocols recommend 5% non-fat dry milk or BSA in TBST, but specific optimization may be required .

• Primary antibody incubation: Incubation at 4°C overnight at dilutions ranging from 1:1000 to 2 μg/mL depending on the specific antibody .

• Storage conditions: Aliquot and store at -20°C to avoid repeated freeze-thaw cycles that can compromise antibody performance .

How does Akirin1 expression differ across tissues and cell types?

Akirin1 expression patterns vary across tissues and cell types:

• Ubiquitous expression: Akirin1 is expressed in most tissues, though at varying levels .

• Cell-type specific regulation:

  • Higher expression in activated proliferating satellite cells compared to quiescent satellite cells

  • Expressed in natural killer cells, making it a potential reference gene

  • Present in macrophages and myoblasts where it may regulate chemotaxis

• Subcellular localization: Predominantly nuclear, consistent with its nuclear localization signal .

When designing experiments, researchers should consider these tissue-specific variations in expression and use appropriate controls.

How can Akirin1 antibodies be used to study protein-protein interactions?

Akirin1 functions as a molecular bridge between proteins, making protein interaction studies particularly valuable:

• Co-immunoprecipitation (Co-IP):

  • Use Akirin1 antibodies conjugated to agarose/magnetic beads to pull down Akirin1 and associated proteins

  • Known interactors include 14-3-3 proteins that regulate Akirin1 function

  • Buffer conditions are critical; use mild lysis buffers (150mM NaCl, 1% NP-40, 50mM Tris pH 8.0) to preserve interactions

• Proximity Ligation Assay (PLA):

  • Combine Akirin1 antibodies with antibodies against suspected interaction partners

  • Particularly useful for detecting transient nuclear interactions with transcription factors

• ChIP-seq applications:

  • Although Akirin1 cannot directly bind DNA, ChIP-seq using Akirin1 antibodies can identify genomic regions where Akirin1 is present as part of transcriptional complexes

  • Has been used to show colocalization with Ser10-phosphorylated Histone H3 and acetylated-H3K9

What methodological approaches can be used to study Akirin1's role in myogenesis?

Akirin1 plays significant roles in skeletal myogenesis, and several methodological approaches can be employed:

• Expression analysis during differentiation:

  • Time-course Western blotting using Akirin1 antibodies during C2C12 myoblast differentiation

  • Akirin1 expression peaks earlier than MyoD during myoblast differentiation

• Functional studies:

  • Combine Akirin1 overexpression/knockdown with immunofluorescence staining of differentiation markers (MyoD, myogenin)

  • Akirin1 overexpression enhances myotube formation and reduces expression of satellite cell markers CD34 and Sca-1

• Signaling pathway analysis:

  • Use Akirin1 antibodies in combination with phospho-specific antibodies (e.g., phospho-Akt) to study the IGF-II-PI3K-Akt signaling pathway

  • Blocking experiments with PI3K inhibitor LY294002 have shown that Akirin1 regulates myogenesis via this pathway

How can researchers investigate Akirin1's role in immune response regulation?

Akirin1 functions in immune regulation can be studied using these methodological approaches:

• Chromatin immunoprecipitation (ChIP):

  • Use Akirin1 antibodies to identify genomic regions where Akirin1 regulates NF-κB-dependent gene expression

  • Akirin1 has been shown to regulate a subset of NF-κB-dependent genes, particularly in the Imd pathway

• Immune challenge models:

  • Compare Akirin1 expression (using Western blot or immunofluorescence) before and after stimulation with LPS or other immune stimulants

  • Studies have shown Akirin1 is dispensable in mouse models while Akirin2 is essential

• Expression correlation analysis:

  • Use Akirin1 antibodies alongside antibodies against IL-6, IP-10, RANTES, and BCL3 to study co-regulation

  • These genes have been identified as Akirin-dependent in immune response pathways

What is the emerging role of Akirin1 in ferroptosis and how can researchers study it?

Recent research has identified Akirin1 as a key player in ferroptosis, particularly in the context of kidney ischemia-reperfusion injury:

• Extracellular vesicle (EV) analysis:

  • Use Akirin1 antibodies to detect and quantify Akirin1 in EVs from biofluids

  • Akirin1 levels in urine-derived EVs 48 hours after kidney transplant can predict delayed graft function

• Mechanistic studies:

  • Investigate Akirin1's interaction with TP53 and SLC7A11 using co-immunoprecipitation and Western blotting

  • Akirin1 activates the EGR1/TP53 axis and inhibits MDM2-mediated TP53 ubiquitination

• Therapeutic targeting:

  • Use Akirin1 antibodies to validate knockdown efficiency in ferroptosis models

  • miR-136-5p has been identified as a potential therapeutic targeting Akirin1 to protect against ferroptosis

Why might I observe multiple bands when using Akirin1 antibodies in Western blotting?

Multiple bands in Western blots using Akirin1 antibodies may occur due to:

• Post-translational modifications: While the predicted molecular weight of Akirin1 is 21.9 kDa, observed bands at higher molecular weights (27 kDa, 68 kDa) may represent phosphorylated or otherwise modified forms .

• Protein-protein interactions: Despite denaturing conditions, some strongly associated proteins may remain bound to Akirin1.

• Cross-reactivity: Some antibodies may cross-react with Akirin2 (which is highly homologous) or other proteins. Specificity tests with blocking peptides can help determine if bands are specific .

• Degradation products: Lower molecular weight bands may represent degradation products, particularly if samples were not properly handled with protease inhibitors.

How can researchers quantitatively compare Akirin1 expression across different experimental conditions?

For quantitative comparisons of Akirin1 expression:

• Western blot normalization:

  • Always normalize to appropriate loading controls (β-actin, GAPDH for total protein; Lamin B for nuclear fractions)

  • Consider using stain-free technology or total protein normalization for more accurate quantification

• Reference gene selection:

  • Akirin1 itself has been identified as a stable reference gene in NK cells and granulocytes during inflammatory conditions

  • When studying Akirin1, validated reference genes such as GAPDH, β-actin, or HPRT should be used

• Quantitative image analysis:

  • Use software like ImageJ for densitometry analysis

  • Include a standard curve of recombinant Akirin1 protein for absolute quantification where possible